Literature DB >> 7980528

Modulators of oxidized LDL-induced hyperadhesiveness in human endothelial cells.

J A Maier1, L Barenghi, S Bradamante, F Pagani.   

Abstract

The adherence of monocytes to the endothelium is an early event in atherogenesis. Our previous studies have demonstrated that oxidized LDL induced U937 cells-endothelial interactions and that HDL prevented oxidized LDL effects. Here, we provide evidence that treatment of endothelial cells with the anti-inflammatory agent indomethacin abolished oxidized LDL as well as interleukin 1- and lipopolysaccharide-stimulated U937 adhesion. It is noteworthy that HDL, which is known to be protective against atherosclerosis, was effective only in negating U937 adhesion induced by oxidized LDL, while it did not affect interleukin 1- and lipopolysaccharide-induced hyperadhesiveness in endothelial cells. Since indomethacin inhibits cyclooxygenase which is the key enzyme in the synthesis of prostanoids, we have studied the effect of oxidized LDL on the expression of cyclooxygenase type 2 and demonstrated that oxidized LDL induces a sustained increase in the expression of cyclooxygenase mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980528     DOI: 10.1006/bbrc.1994.2512

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

Authors:  Francesco Cipollone; Maria Luigia Fazia
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

2.  Impact of maternal dexamethasone on coronary PGE(2) production and prostaglandin-dependent coronary reactivity.

Authors:  Robert D Roghair; Kenneth A Volk; Fred S Lamb; Jeffrey L Segar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-25       Impact factor: 3.619

3.  Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.

Authors:  A Zembowicz; S L Jones; K K Wu
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 4.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.